Related Experiment Video
Updated: Aug 21, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction
Chun Crowder1, Øyvind Dahle, R Eric Davis
1Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Interferon (IFN) induces expression of proapoptotic genes and has been used in the clinical treatment of multiple myeloma. The promyelocytic leukemia (PML) gene is an IFN-induced target that encodes a tumor suppressor protein. PML protein is typically localized within discrete speckled nuclear structures termed PML nuclear bodies (NBs). Multiple myeloma cells demonstrate differential responses to IFN treatment, the mechanism of which is largely unknown. Herein, we show that growth inhibition effects of IFN-alpha in myeloma cells correlate with PML NBs and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induction, whereas known IFN targets including signal transducer and activator of transcription-1 (STAT1), STAT3, p38, and Daxx cannot account for these differential responses. RNAi silencing of PML blocks IFN-alpha-induced apoptosis in myeloma cells and correspondingly down-regulates TRAIL expression. Similarly, stable expression of a dominant negative TRAIL receptor DR5 partially blocks IFN-induced cell death. These results demonstrate that PML and TRAIL play important roles in IFN-induced apoptosis and identify TRAIL as a novel downstream transcriptional target of PML. Identification of PML and PML NBs as effectors of IFN responses provides insights into mechanisms by which tumor cells exhibit resistance to this class of agents and may prove useful in assessing treatment regimens.
Insights
Interferon (IFN) treatment
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Interferon (IFN) is used clinically for multiple myeloma and induces proapoptotic genes.
- The promyelocytic leukemia (PML) gene, an IFN target, encodes a tumor suppressor protein found in PML nuclear bodies (NBs).
- Mechanisms underlying differential responses of multiple myeloma cells to IFN are not fully understood.
Purpose of the Study:
- To investigate the roles of PML nuclear bodies (NBs) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in IFN-alpha-induced apoptosis in multiple myeloma.
- To identify downstream targets of PML involved in IFN-alpha-mediated anti-myeloma effects.
Main Methods:
- Correlated IFN-alpha-induced growth inhibition with PML NBs and TRAIL expression in myeloma cells.
- Utilized RNA interference (RNAi) to silence PML expression.
- Assessed the effect of dominant-negative TRAIL receptor (DR5) expression on IFN-induced cell death.
Main Results:
- IFN-alpha's growth inhibition in myeloma cells correlated with PML NBs and TRAIL induction, not with known IFN targets like STAT1, STAT3, p38, or Daxx.
- PML silencing abrogated IFN-alpha-induced apoptosis and reduced TRAIL expression.
- Expression of a dominant-negative TRAIL receptor partially inhibited IFN-induced myeloma cell death.
Conclusions:
- PML and TRAIL are critical effectors of IFN-alpha-induced apoptosis in multiple myeloma.
- TRAIL is identified as a novel downstream transcriptional target of PML.
- Understanding PML and PML NBs' roles offers insights into IFN resistance mechanisms in tumor cells and aids in treatment assessment.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...